Marion Odence-Ford - Aug 21, 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Legal & Admin Officer
Signature
/s/ Marion K. Odence-Ford
Stock symbol
OPRX
Transactions as of
Aug 21, 2025
Transactions value $
$0
Form type
4
Date filed
8/25/2025, 04:29 PM
Previous filing
Mar 4, 2025
Next filing
Oct 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Odence-Ford Marion Chief Legal & Admin Officer C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM /s/ Marion K. Odence-Ford 2025-08-25 0001845002

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Award $0 +15.6K +22.23% $0.00 85.9K Aug 21, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +35.2K $0.00 35.2K Aug 21, 2025 Common Stock 35.2K $16.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
F2 The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.